WeVote
Log In

Bill

Bill

A 1890

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

2024-2025 Regular Session Introduced by Annette Quijano

New Jersey bill requiring registration and regulatory oversight of hemp-derived cannabinoid manufacturers and sellers to ensure product safety and market consistency.

Introduced in the Assembly, Referred to Assembly Oversight, Reform and Federal Relations Committee
#marijuana
0
WeVote Research Nonpartisan
Bill Summary · A 1890

Legislative bill overview

Bill A 1890 establishes a registration and regulatory framework for hemp-derived cannabinoids sold in New Jersey. The bill requires manufacturers and sellers of these products to register with state authorities and comply with specified regulations, rather than allowing completely unregulated sales.

Why is this important

Hemp-derived cannabinoids (like delta-8 THC, delta-10 THC, and HHC) exist in a legal gray area under federal law but have proliferated in retail markets with minimal oversight. This creates consumer safety concerns regarding product quality, potency labeling accuracy, and potential contamination, while also affecting legitimate cannabis businesses operating under strict state regulations.

Potential points of contention

  • Definitional scope: Determining which cannabinoids qualify as "hemp-derived" versus controlled substances, and whether regulations keep pace with emerging synthetic variants
  • Business impact: Retail sector concerns about compliance costs, licensing fees, and whether regulations disadvantage small operators versus large corporations
  • Regulatory authority: Questions about which state agency oversees this framework and whether it duplicates or conflicts with existing cannabis commission regulations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.